Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox in MDS Patients With Chronic Transfusional Hemosiderosis
NCT00469560Phase 3Completed
- Sponsor
- GIMEMA
- Start
- Jun 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deferasirox in hemosiderosis, sponsored by GIMEMA. Started Jun 2007; status: completed.
02
Drugs
deferasirox
03
Conditions
hemosiderosis
Beyond the preview
Go deeper on NCT00469560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469560.